Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families.

Peshkin BN, Ladd MK, Isaacs C, Segal H, Jacobs A, Taylor KL, Graves KD, O'Neill SC, Schwartz MD.

J Cancer Educ. 2019 Aug 11. doi: 10.1007/s13187-019-01599-y. [Epub ahead of print]

PMID:
31402434
2.

Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

Ladd MK, Peshkin BN, Senter L, Baldinger S, Isaacs C, Segal H, Philip S, Phillips C, Shane K, Martin A, Weinstein V, Pilarski R, Jeter J, Sweet K, Hatten B, Wurtmann EJ, Phippen S, Bro D, Schwartz MD.

Transl Behav Med. 2018 Nov 10. doi: 10.1093/tbm/iby101. [Epub ahead of print]

PMID:
30418620
3.

Patient-Reported Outcome Measures (PROM) as A Preoperative Assessment Tool.

Kim S, Duncan PW, Groban L, Segal H, Abbott RM, Williamson JD.

J Anesth Perioper Med. 2017 Nov 28;4(6):274-281. Epub 2017 Nov 2.

4.

Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.

Interrante MK, Segal H, Peshkin BN, Valdimarsdottir HB, Nusbaum R, Similuk M, DeMarco T, Hooker G, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Heinzmann J, Kinney AY, Schwartz MD.

JNCI Cancer Spectr. 2017 Sep;1(1):pkx002. doi: 10.1093/jncics/pkx002. Epub 2017 Sep 22.

5.

Electrochemical and structural characterization of Azotobacter vinelandii flavodoxin II.

Segal HM, Spatzal T, Hill MG, Udit AK, Rees DC.

Protein Sci. 2017 Oct;26(10):1984-1993. doi: 10.1002/pro.3236. Epub 2017 Aug 30.

6.

Development and Implementation of a Tool to Assess Patient-Reported Outcome Measures (PROM) in Preoperative Setting.

Kim S, Duncan PW, Groban L, Segal H, Abbott RM, Williamson JD.

Glob J Perioper Med. 2017;1:017-21. doi: 10.17352/gjpm.000005. Epub 2017 Nov 16.

7.

Molecular magnetic resonance imaging discloses endothelial activation after transient ischaemic attack.

Quenault A, Martinez de Lizarrondo S, Etard O, Gauberti M, Orset C, Haelewyn B, Segal HC, Rothwell PM, Vivien D, Touzé E, Ali C.

Brain. 2017 Jan;140(1):146-157. doi: 10.1093/brain/aww260. Epub 2016 Nov 8.

8.

Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study.

Greisenegger S, Segal HC, Burgess AI, Poole DL, Mehta Z, Rothwell PM.

Stroke. 2015 Nov;46(11):3117-23. doi: 10.1161/STROKEAHA.115.011021. Epub 2015 Oct 8.

PMID:
26451023
9.

Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory.

Ballinger MD, Saito A, Abazyan B, Taniguchi Y, Huang CH, Ito K, Zhu X, Segal H, Jaaro-Peled H, Sawa A, Mackie K, Pletnikov MV, Kamiya A.

Neurobiol Dis. 2015 Oct;82:176-184. doi: 10.1016/j.nbd.2015.06.006. Epub 2015 Jun 18.

10.

Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study.

Greisenegger S, Segal HC, Burgess AI, Poole DL, Mehta Z, Rothwell PM.

Stroke. 2015 Mar;46(3):659-66. doi: 10.1161/STROKEAHA.114.007624. Epub 2015 Feb 3.

11.

Population-based study of blood biomarkers in prediction of subacute recurrent stroke.

Segal HC, Burgess AI, Poole DL, Mehta Z, Silver LE, Rothwell PM.

Stroke. 2014 Oct;45(10):2912-7. doi: 10.1161/STROKEAHA.114.005592. Epub 2014 Aug 26.

12.

DNA-mediated signaling by proteins with 4Fe-4S clusters is necessary for genomic integrity.

Grodick MA, Segal HM, Zwang TJ, Barton JK.

J Am Chem Soc. 2014 Apr 30;136(17):6470-8. doi: 10.1021/ja501973c. Epub 2014 Apr 16.

13.

Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression.

Kaminitz A, Barzilay R, Segal H, Taler M, Offen D, Gil-Ad I, Mechoulam R, Weizman A.

World J Biol Psychiatry. 2014 Jan;15(1):76-82. doi: 10.3109/15622975.2013.841993. Epub 2013 Nov 13.

PMID:
24219803
14.

17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status.

Adib-Samii P, Rost N, Traylor M, Devan W, Biffi A, Lanfranconi S, Fitzpatrick K, Bevan S, Kanakis A, Valant V, Gschwendtner A, Malik R, Richie A, Gamble D, Segal H, Parati EA, Ciusani E, Holliday EG, Maguire J, Wardlaw J, Worrall B, Bis J, Wiggins KL, Longstreth W, Kittner SJ, Cheng YC, Mosley T, Falcone GJ, Furie KL, Leiva-Salinas C, Lau BC, Saleem Khan M; Australian Stroke Genetics Collaborative; Wellcome Trust Case-Control Consortium-2 (WTCCC2); METASTROKE, Sharma P, Fornage M, Mitchell BD, Psaty BM, Sudlow C, Levi C, Boncoraglio GB, Rothwell PM, Meschia J, Dichgans M, Rosand J, Markus HS; International Stroke Genetics Consortium.

Stroke. 2013 Jun;44(6):1609-15. doi: 10.1161/STROKEAHA.113.679936. Epub 2013 May 14.

15.

Fabry disease in unselected patients with TIA or stroke: population-based study.

Marquardt L, Baker R, Segal H, Burgess AI, Poole D, Hughes DA, Rothwell PM.

Eur J Neurol. 2012 Nov;19(11):1427-32. doi: 10.1111/j.1468-1331.2012.03739.x. Epub 2012 Apr 27.

PMID:
22537551
16.

Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke.

International Stroke Genetics Consortium (ISGC); Wellcome Trust Case Control Consortium 2 (WTCCC2), Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M, Jackson CA, Traylor M, Strange A, Su Z, Band G, Syme PD, Malik R, Pera J, Norrving B, Lemmens R, Freeman C, Schanz R, James T, Poole D, Murphy L, Segal H, Cortellini L, Cheng YC, Woo D, Nalls MA, Müller-Myhsok B, Meisinger C, Seedorf U, Ross-Adams H, Boonen S, Wloch-Kopec D, Valant V, Slark J, Furie K, Delavaran H, Langford C, Deloukas P, Edkins S, Hunt S, Gray E, Dronov S, Peltonen L, Gretarsdottir S, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boncoraglio GB, Parati EA, Attia J, Holliday E, Levi C, Franzosi MG, Goel A, Helgadottir A, Blackwell JM, Bramon E, Brown MA, Casas JP, Corvin A, Duncanson A, Jankowski J, Mathew CG, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Trembath RC, Viswanathan AC, Wood NW, Worrall BB, Kittner SJ, Mitchell BD, Kissela B, Meschia JF, Thijs V, Lindgren A, Macleod MJ, Slowik A, Walters M, Rosand J, Sharma P, Farrall M, Sudlow CL, Rothwell PM, Dichgans M, Donnelly P, Markus HS.

Nat Genet. 2012 Feb 5;44(3):328-33. doi: 10.1038/ng.1081.

17.

Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.

Evans J, Segal H.

J Antimicrob Chemother. 2010 May;65(5):897-900. doi: 10.1093/jac/dkq047. Epub 2010 Feb 25.

PMID:
20185419
18.

Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.

Kunicki TJ, Williams SA, Nugent DJ, Harrison P, Segal HC, Syed A, Rothwell PM.

Thromb Haemost. 2009 Jan;101(1):123-33.

PMID:
19132198
19.

Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.

Evans J, Stead MC, Nicol MP, Segal H.

J Antimicrob Chemother. 2009 Jan;63(1):11-6. doi: 10.1093/jac/dkn433. Epub 2008 Oct 21.

PMID:
18940875
20.

Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests.

Harrison P, Segal H, Silver L, Syed A, Cuthbertson FC, Rothwell PM.

Platelets. 2008 Mar;19(2):119-24. doi: 10.1080/09537100701771736.

PMID:
18297549
21.

Shiga toxin gene-containing Escherichia coli from cattle and diarrheic children in the pastoral systems of southwestern Uganda.

Majalija S, Segal H, Ejobi F, Elisha BG.

J Clin Microbiol. 2008 Jan;46(1):352-4. Epub 2007 Nov 7.

22.

A novel insertion sequence, ISPA26, in oprD of Pseudomonas aeruginosa is associated with carbapenem resistance.

Evans JC, Segal H.

Antimicrob Agents Chemother. 2007 Oct;51(10):3776-7. Epub 2007 Aug 6. No abstract available.

23.

Extended -10 promoter in ISAba-1 upstream of blaOXA-23 from Acinetobacter baumannii.

Segal H, Jacobson RK, Garny S, Bamford CM, Elisha BG.

Antimicrob Agents Chemother. 2007 Aug;51(8):3040-1. Epub 2007 Jun 4. No abstract available.

24.

Comparative proteomics of small cell lung carcinoma.

Ziv T, Barnea E, Segal H, Sharon R, Beer I, Admon A.

Cancer Biomark. 2006;2(6):219-34.

PMID:
17264394
25.

AML-loaded DC generate Th1-type cellular immune responses in vitro.

Xing D, Decker WK, Li S, Robinson SN, Yang H, Segal H, O'Connor S, Yao X, Komanduri KV, McMannis JD, Jones RB, de Lima M, Champlin RE, Shpall EJ.

Cytotherapy. 2006;8(2):95-104.

PMID:
16698683
26.

Grouping does not require attention.

Lamy D, Segal H, Ruderman L.

Percept Psychophys. 2006 Jan;68(1):17-31.

PMID:
16617826
27.

Methods for counting platelets in severe thrombocytopenia.

Segal HC, Harrison P.

Curr Hematol Rep. 2006 Mar;5(1):70-5. Review.

PMID:
16537049
28.

Platelet function (measured by Platelet Function Analyser--100) and obstructive sleep apnoea.

West S, Segal H, Harrison P, Stradling J.

J Sleep Res. 2005 Sep;14(3):325-7. No abstract available.

29.

Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii.

Segal H, Elisha BG.

J Antimicrob Chemother. 2005 Sep;56(3):598. Epub 2005 Jul 26. No abstract available.

PMID:
16046465
30.

Impact of immunological platelet counting (by the platelet/RBC ratio) on haematological practice.

Harrison P, Segal H, Briggs C, Murphy M, Machin S.

Cytometry B Clin Cytom. 2005 Sep;67(1):1-5. Review. No abstract available.

31.

A pilot genetic study of the continuum between compulsivity and impulsivity in females: the serotonin transporter promoter polymorphism.

Baca-García E, Salgado BR, Segal HD, Lorenzo CV, Acosta MN, Romero MA, Hernández MD, Saiz-Ruiz J, Fernandez Piqueras J, de Leon J.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):713-7.

PMID:
15908092
32.

Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry.

Harrison P, Segal H, Blasbery K, Furtado C, Silver L, Rothwell PM.

Stroke. 2005 May;36(5):1001-5. Epub 2005 Apr 7.

PMID:
15817896
33.

Is IS(ABA-1) customized for Acinetobacter?

Segal H, Garny S, Elisha BG.

FEMS Microbiol Lett. 2005 Feb 15;243(2):425-9.

34.

Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion.

Segal HC, Briggs C, Kunka S, Casbard A, Harrison P, Machin SJ, Murphy MF.

Br J Haematol. 2005 Feb;128(4):520-5.

PMID:
15686462
35.

Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.

Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR.

Thorax. 2004 Sep;59(9):777-82.

36.

High incidence of defective high-shear platelet function among platelet donors.

Harrison P, Segal H, Furtado C, Verjee S, Sukhu K, Murphy MF.

Transfusion. 2004 May;44(5):764-70.

PMID:
15104660
37.

Role of class A penicillin-binding proteins in PBP5-mediated beta-lactam resistance in Enterococcus faecalis.

Arbeloa A, Segal H, Hugonnet JE, Josseaume N, Dubost L, Brouard JP, Gutmann L, Mengin-Lecreulx D, Arthur M.

J Bacteriol. 2004 Mar;186(5):1221-8.

38.

Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate.

Segal H, Nelson EC, Elisha BG.

Antimicrob Agents Chemother. 2004 Feb;48(2):612-4.

39.

Outer membrane protein alterations and blaTEM-1 variants: their role in beta-lactam resistance in Klebsiella pneumoniae.

Nelson EC, Segal H, Elisha BG.

J Antimicrob Chemother. 2003 Dec;52(6):899-903. Epub 2003 Nov 12.

PMID:
14613957
40.

The key to healthcare reform: context and content.

Segal HD.

Healthc Pap. 2000 Summer;1(3):22-4; discussion 88-91. No abstract available.

PMID:
12811187
42.

Future events, early experience, and mental health: clinical assessment using the anticipated life history measure.

Segal HG, Wood GA, DeMeis DK, Smith HL.

Assessment. 2003 Mar;10(1):29-40.

PMID:
12675381
43.
44.

A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.

Arcasoy MO, Karayal AF, Segal HM, Sinning JG, Forget BG.

Blood. 2002 Apr 15;99(8):3066-9.

PMID:
11929803
45.

Canadian Cardiovascular Congress address: why no one in government listens to doctors.

Segal HD.

Can J Cardiol. 2002 Mar;18(3):251-3. No abstract available.

PMID:
11907612
46.

T cells from newborn humans are fully capable of developing into cytotoxic T lymphocyte effector cells in adoptive hosts.

Marcus H, Dekel B, Arditti FD, Reich-Zeliger S, Segal H, Bocher WO, Reisner Y.

Transplantation. 2002 Mar 15;73(5):803-10.

PMID:
11907431
47.

Victor and victim.

Segal HP.

Nature. 2001 Aug 30;412(6850):861. No abstract available.

PMID:
11528455
48.
49.
50.

Back to the future from 1888.

Segal HP.

Nature. 2001 Feb 1;409(6820):563. No abstract available.

PMID:
11214298

Supplemental Content

Support Center